A cooling pack is provided that can both maintain the human body at a suitable, low temperature and ensure a sufficient usage time. The present invention, in one aspect thereof, is directed to a cooling pack that cools a human body. The cold storage layer includes: a freezing medium having a phase transition temperature specified in a range of temperature suitable to maintain the human body at low temperature; and a cold-storage-layer-packaging member containing the freezing medium therein. The buffer layer includes: an antifreeze medium flexible at the phase transition temperature of the freezing medium; and a buffer-layer-packaging member made of a flexible material and containing the antifreeze medium therein. The buffer layer has a prescribed thermal conductivity, thermal diffusivity, thermal effusivity, and heat transmission coefficient. The buffer layer is brought into contact with human skin to transfer heat between the human body and the cold storage layer.

The field of the invention relates generally to devices and methods for controlling the temperature of a human or non-human body. More specifically, the field of the invention may relate to wearable devices, which may be worn by a subject, which human or non-human, wherein the wearable device is in thermal communication with a portion of the subject's body containing brown adipose tissue and wherein the wearable device comprises a means for providing a constant or near constant temperature to the subject's body and therefore controls the temperature of the subject's body, by using a phase change material. The phase material transitions state at a predetermined temperature which may be higher or lower than the subject's exterior body temperature. The device and method are usable to control temperature-related effects of menopause, post menopause and drug induced thermoregulatory symptoms such as night sweats, hot flashes and sleep disturbance.

The present invention relates to a life cradle device for the purpose of inducing therapeutic hypothermia in neonates suffering from birth asphyxia. The device essentially consists of a rigid outer skeleton which could be fitted with removable mattresses containing form stable organic phase change materials effecting instant and sustained cooling. Multiple compartments of different phase change material composition functional at different temperatures are arranged in layers to replicate cooling performances as in conventional cascading systems. The device is also designed to have thermo-chromic indicators with an option of probes for automation control techniques. The device may also be fitted with thermostat controlled infant radiant warmer to automatically switch on when the infant is cooled down below requirement as a safety consideration.

Implementations described herein include a device comprising a frame and an energy source operably coupled to the frame that applies energy to eyelids and allows for normal blinking of the eye. The frame is securably positionable on a face of a user. The frame includes an engagement portion operably coupled to a support portion. The engagement portion is positionable over an eye of a user. The engagement portion extends between a medial side and a lateral side thereof. The support portion is securable to the face of the user peripheral to an eye area thereof. The eye area includes both the upper eyelid and the lower eyelid of the eye. The engagement portion can be a first engagement portion and the frame can further include a second engagement portion spaced apart from the first engagement portion. The first engagement portion and the second engagement portion can be coupled via a support portion extending therebetween.

A means can be used instead of or with conventional temperature control to achieve warming device temperature control at a lower cost, prevent or reduce deterioration of a warming device over time, and lower generated heat temperature due to storage at high temperatures. The warming device can be used for the same. A higher level temperature control means can be used for warming devices for medical applications. An improved warming device can be used for medical applications with a high level of safety and efficacy. A temperature control agent controls a maximum temperature of a warming device with a heat generating composition that generates heat by reaction with oxygen. Said agent includes an aliphatic compound that has a particle form that will not pass through a standard sieve with a #60 mesh, a melting point of 35-65? C., and an aqueous solubility (g/100 mL) at 20? C. of ?5.

The present invention relates to a novel cryogenic composition intended to be used in thermal treatment devices, and also to its process of preparation. The invention also relates to a thermal treatment device and more particularly to a medical device used to cool a part of the human or animal body, in particular after trauma, inflammation or a surgical act. The invention has application in the therapeutic and/or medical field but also in other fields, such as, for example, for the cooling or the maintenance at low temperature of foodstuffs.

A personal cooling system for maintaining an individual at a preferred predetermined temperature in the outdoor environment of a venue, for an extended period of time, according to one embodiment includes a first cooling element comprising a phase change material (PCM) and at least one cooling station for providing any one of an additional one or more frozen cooling elements, each having a PCM, and at least one freezing medium for freezing any of said cooling elements. The cooling station is installed at the venue.

An economical dual modality system can be manufactured and used in a method including the steps of assembling a system including a durable energy subsystem and a replaceable thermal subsystem, activating the replaceable thermal subsystem, attaching the system to a desired treatment area of a user's body, and activating the durable energy subsystem. The durable energy subsystem is arranged and configured to deliver energy, and the replaceable thermal subsystem is arranged and configured to be coupled to the durable energy subsystem arranged and configured to deliver thermal energy. The replaceable thermal subsystem delivers thermal energy to the desired treatment area at a predetermined temperature range for at least 30 minutes, and the durable energy subsystem delivers energy from the group consisting of non-visible light electromagnetic radiation, visible light radiation, electromagnetic field, microcurrent, electrical stimulation, iontophoresis, sonophoresis and combinations thereof independently of the thermal energy.

A dual modality system includes a flexible chassis including a durable energy subsystem and a replaceable thermal subsystem. The durable energy subsystem has a plurality of energy emitters disposed in an emission region of the chassis having a length and a width, wherein the emission region length and emission region width are both substantially greater than an emission region depth. The replaceable thermal subsystem has a thermal source affixed to flexible web having an adhesive surface and at least one structure arranged and configured to couple the thermal subsystem to a chassis comprising a durable energy subsystem in a configuration wherein the thermal source is substantially superposed over the emission region of the chassis.

A dual modality system includes a chassis having a receptacle and means to couple the chassis to a desired treatment area of a user's body; a durable energy subsystem coupled to the chassis, arranged and configured to deliver energy to the desired treatment area of a user's body; and a replaceable thermal subsystem arranged and configured for removable placement in the receptacle of the chassis, arranged and configured to deliver thermal energy.